[go: up one dir, main page]

NO20052524D0 - Aminerte isofiavonoidderivater og anvendelse derav - Google Patents

Aminerte isofiavonoidderivater og anvendelse derav

Info

Publication number
NO20052524D0
NO20052524D0 NO20052524A NO20052524A NO20052524D0 NO 20052524 D0 NO20052524 D0 NO 20052524D0 NO 20052524 A NO20052524 A NO 20052524A NO 20052524 A NO20052524 A NO 20052524A NO 20052524 D0 NO20052524 D0 NO 20052524D0
Authority
NO
Norway
Prior art keywords
isofiavonoid
aminated
derivatives
isofiavonoid derivatives
aminated isofiavonoid
Prior art date
Application number
NO20052524A
Other languages
English (en)
Other versions
NO20052524L (no
Inventor
Andrew Heaton
Graham Edmund Kelly
Jane Faragalla
John Bremner
Original Assignee
Novogen Res Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novogen Res Pty Ltd filed Critical Novogen Res Pty Ltd
Publication of NO20052524D0 publication Critical patent/NO20052524D0/no
Publication of NO20052524L publication Critical patent/NO20052524L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/68—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
NO20052524A 2002-11-01 2005-05-26 Aminerte isofiavonoidderivater og anvendelse derav NO20052524L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2002952453A AU2002952453A0 (en) 2002-11-01 2002-11-01 Aminated isoflavonoid derivatives and uses thereof
PCT/AU2003/001446 WO2004039793A1 (en) 2002-11-01 2003-11-03 Aminated isoflavonoid derivatives and uses thereof

Publications (2)

Publication Number Publication Date
NO20052524D0 true NO20052524D0 (no) 2005-05-26
NO20052524L NO20052524L (no) 2005-05-26

Family

ID=28795843

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052524A NO20052524L (no) 2002-11-01 2005-05-26 Aminerte isofiavonoidderivater og anvendelse derav

Country Status (10)

Country Link
US (1) US7714151B2 (no)
EP (1) EP1556368A4 (no)
JP (1) JP2006513997A (no)
CN (1) CN1708490A (no)
AU (1) AU2002952453A0 (no)
CA (1) CA2504653A1 (no)
MX (1) MXPA05004526A (no)
NO (1) NO20052524L (no)
NZ (1) NZ539034A (no)
WO (1) WO2004039793A1 (no)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1615906A1 (en) * 2003-04-03 2006-01-18 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of protein kinases
FR2873118B1 (fr) * 2004-07-15 2007-11-23 Sanofi Synthelabo Derives de pyrido-pyrimidine, leur application en therapeutique
JP2006146490A (ja) * 2004-11-18 2006-06-08 Ricoh Co Ltd 印刷制御装置及び印刷制御プログラム
CA2588180A1 (en) * 2004-12-17 2006-06-22 Bionovo, Inc. Method of using extracts of epimedium species
DE102005011822A1 (de) * 2005-03-15 2006-09-21 Merck Patent Gmbh Phthalazinone
US20090131513A1 (en) * 2005-03-24 2009-05-21 Novogen Research Pty Ltd. Anti-inflammatory modalities
US7482029B2 (en) * 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
FR2887882B1 (fr) * 2005-07-01 2007-09-07 Sanofi Aventis Sa Derives de pyrido[2,3-d] pyrimidine, leur preparation, leur application en therapeutique
US7528267B2 (en) 2005-08-01 2009-05-05 Girindus America, Inc. Method for enantioselective hydrogenation of chromenes
US7700136B2 (en) * 2005-11-14 2010-04-20 Bionovo, Inc. Scutellaria barbata extract for the treatment of cancer
US20090042818A1 (en) * 2007-06-22 2009-02-12 Bionovo, Inc. Liquiritigenin and Derivatives as Selective Estrogen Receptor Beta Agonists
US20080319051A1 (en) * 2007-06-22 2008-12-25 Bionovo, Inc. Liquiritigenin and derivatives as selective estrogen receptor beta agonists
AU2008285325A1 (en) * 2007-08-08 2009-02-12 Bionovo, Inc. Extracts of Ligustrum lucidum and uses thereof
EP2203178A4 (en) * 2007-09-07 2012-03-21 Bionovo Inc ESTROGENEXTRACTS FROM PUERARIA LOBATA WILLD, OHWI FROM THE FAMILY OF LEGUMINOSAE AND APPLICATIONS THEREOF
EP2194998A4 (en) * 2007-09-07 2012-03-21 Bionovo Inc STROGENIC EXTRACTS OF ASPARAGUS CONCHINCHINENSIS (LOUR.) MERR OF THE LILIACEAE FAMILY AND USES THEREOF
JP2010538093A (ja) * 2007-09-07 2010-12-09 バイオノボ・インコーポレーテッド シソ科ファミリーのセイタカナミキソウのエストロゲン性抽出物およびその使用
JP2010539085A (ja) * 2007-09-07 2010-12-16 バイオノボ・インコーポレーテッド マメ科ファミリーのキバナオウギのエストロゲン性抽出物およびその使用
AU2008326431A1 (en) * 2007-11-19 2009-05-28 Bionovo, Inc. Scutellaria barbata extract and combinations for the treatment of cancer
US20090130101A1 (en) * 2007-11-19 2009-05-21 Bionovo, Inc. Anti-cancer therapy with an extract of scutellaria barbata
CA2706313A1 (en) 2007-11-19 2009-05-28 Bionovo, Inc. Methods of detecting and treatment of cancers using scuttelaria barbata extract
EP2222323A4 (en) 2007-11-19 2012-07-25 Bionovo Inc PROCESS FOR PREPARING A CLEANED EXTRACT OF SCUTELLARIA BARBATA D. DON
TWI324514B (en) * 2008-02-26 2010-05-11 Univ Kaohsiung Medical Isoflavone derivatives and pharmaceutical compositions comprising the same
US20090258942A1 (en) * 2008-04-14 2009-10-15 Bionovo, Inc. Calycosin and analogs thereof for the treatment of estrogen receptor beta-mediated diseases
CA2723403A1 (en) * 2008-05-06 2009-11-12 Bionovo, Inc. Estrogenic extracts for use in treating vaginal and vulvar atrophy
JP2011523713A (ja) * 2008-06-05 2011-08-18 バイオノボ・インコーポレーテッド 植物組成物由来の多種類の生体活性物質の定量方法
US20090312437A1 (en) * 2008-06-06 2009-12-17 Bionovo, Inc., A Delaware Corporation Anthraquinones and Analogs from Rhuem palmatum for Treatment of Estrogen Receptor Beta-Mediated Conditions
JP2012501974A (ja) * 2008-09-03 2012-01-26 バイオノボ・インコーポレーテッド 癌の処置のための方法および組成物
WO2010085788A1 (en) * 2009-01-26 2010-07-29 Primus Pharmaceuticals, Inc. Methods of treating muscular dystrophies
US20100303936A1 (en) * 2009-04-28 2010-12-02 Bionovo, Inc. A Delaware Corporation Method of reducing fat accumulation and inducing weight loss
CN101716135B (zh) * 2010-01-08 2012-11-14 山西医科大学 大豆异黄酮固体分散体栓剂及其制备方法
CN102453028B (zh) * 2010-10-22 2014-07-30 沈阳药科大学 抗真菌剂—2-[（2，3-二氢-4H-苯并[b]噻喃-4-亚基）亚肼基]-4-氧代四氢噻（噁）唑-5-乙酸衍生物
US10568900B1 (en) 2013-03-15 2020-02-25 Suzanne Janine Paxton-Pierson Androgen effectors
JP6744860B2 (ja) * 2014-09-10 2020-08-19 システム バイオロジー アーゲー イソフラバンおよびその中間体の合成
WO2017173498A1 (en) 2016-04-06 2017-10-12 Noxopharm Limited Isoflavonoid composition with improved pharmacokinetics
AU2017247006B2 (en) * 2016-04-06 2022-05-12 Noxopharm Limited Radiotherapy improvements
JP2023519990A (ja) 2020-03-30 2023-05-15 ノクソファーム リミティド 感染に関連する炎症の治療のための方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2067092C1 (ru) * 1988-12-27 1996-09-27 Е.И.Дюпон Де Немур Энд Компани Производные семикарбазонов, способ уничтожения артроподов, артроподицидная композиция
MX18911A (es) * 1988-12-27 1993-10-01 Du Pont Artropodicidas de semicarbazonas substituidas.
AU1886892A (en) * 1991-04-12 1992-11-17 Schering Corporation Bicyclic amides as inhibitors of acyl-coenzyme a: cholesterol acyl transferase
CN1093086A (zh) * 1993-04-03 1994-10-05 华西医科大学药物研究所 异黄酮脂环烃醚及其肟衍生物

Also Published As

Publication number Publication date
NO20052524L (no) 2005-05-26
WO2004039793A1 (en) 2004-05-13
US7714151B2 (en) 2010-05-11
US20060100238A1 (en) 2006-05-11
JP2006513997A (ja) 2006-04-27
MXPA05004526A (es) 2005-07-26
EP1556368A1 (en) 2005-07-27
NZ539034A (en) 2008-04-30
AU2002952453A0 (en) 2002-11-21
CN1708490A (zh) 2005-12-14
CA2504653A1 (en) 2004-05-13
EP1556368A4 (en) 2010-07-28

Similar Documents

Publication Publication Date Title
NO20052524D0 (no) Aminerte isofiavonoidderivater og anvendelse derav
IS2504B (is) Fosfónóoxýkínasólínafleiður og lyfjafræileg notkun þeirra
NO2017017I1 (no) umeklinidium og vilanterol
DK1592686T3 (da) Gyrase-inhibitorer og anvendelser deraf
IS6934A (is) Nýjar spírótrísýklískar afleiður og notkun þeirrasem fosfódíesterasa-7-hindrar
DK1465615T3 (da) Tricykliske bisenonderivater og fremgangsmåder til anvendelse heraf
DK2305250T3 (da) Benzimidazolderivater og anvendelse heraf som proteinkinaseinhibitorer
IS3007B (is) Ónæmisbælandi efnasambönd og efnablöndur
DK1711207T3 (da) Interferon-alpha-antistoffer og anvendelse heraf
IS2599B (is) 3-fenýlsúlfónýl-8-píperasín-1-ýl-kínólín og lyfjafræðilega viðurkenndar afleiður þess
IS8146A (is) Setnar 3-alkýl og 3-alkenýl asetidín afleiður
IS8329A (is) Kínólínafleiður og notkun þeirra í meðferð
NO20040640L (no) Anordning og fremgangsmate
IS7701A (is) Arípíprazól samsett lyfjaform og aðferð
IS8392A (is) Heterósýklískir hindrar MEK og notkun þeirra
NO20041975L (no) Bicyklisk oksopyridin og oksopyrimidinderivater
NO20054453D0 (no) P38 inhibitorer og fremgangsmater for anvendelse derav
IS8529A (is) Rífamísínhliðstæður og notkun þeirra
DK1554250T3 (da) Hidtil ukendt lactamer og anvendelser deraf
DK1771421T3 (da) N-hydroxyamidderivater og anvendelse deraf
DK1513836T3 (da) Piperazinylacylpiperidinderivater, fremstilling og terapeutisk anvendelse heraf
NO20053593D0 (no) Arylalkylkarbamat-derivater, fremgangsmate og anvendelse derav i terapi
DK1601744T3 (da) Forgasningsapparat og fremgangsmåde
IS8489A (is) Umritunarstillar og aðferðir þeirra
DK1562918T3 (da) Substituerede benzoxazinoner og anvendelser deraf

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application